Quarterly Statement as of 30 June 2023
BRAIN Biotech AG, 30 August 2023
English version see below German version
Our products and solutions directly address the sustainability goals of the United Nations: 2, 3, 6, 9, and 12.
Among other things, we aim to replace petrochemical processes by biotechnological processes, based on our proprietary resource collection, the BRAIN BioArchive.
Our innovative solutions (Tailor-made-solutions, TMS) as well as our products business show a low correlation with economic cycles and enable structural growth.
We have a broad and profound technological expertise in enzymes, microorganisms, cell-based testing methods and natural products. Combined with our collection of natural resources, the BRAIN BioArchive, we develop disruptive new biobased products and solutions.
In more than 150 successfully completed R&D partnerships (Tailor made Solutions, TMS) we have proven our competence and reliability.
Our proprietary BRAIN BioArchive, an extensive patent portfolio, our broad and in-depth technology know-how as well as our first class scientists build high barriers to market entry.